Evidence map›Paper›PMID 35702824›Full record

ArticleGenetic epidemiology2022

Novel HLA associations with outcomes of Mycobacterium tuberculosis exposure and sarcoidosis in individuals of African ancestry using nearest-neighbor feature selection.

Bryan A Dawkins, Lori Garman, Nicholas Cejda, Nathan Pezant, Astrid Rasmussen, Benjamin A Rybicki, Albert M Levin, Penelope Benchek, Chetan Seshadri, Harriet Mayanja-Kizza and 3 more

Open access · greenAbstract read
In one paragraph

Article in Genetic epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Americas Association of Sarcoidosis and other granulomatous disorders 2024 conference highlights.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Sarcoidosis,Microorganisms · 2023
    Review
  9. Genetics of neurosarcoidosis.Journal of neuroimmunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Bryan A DawkinsDepartment of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-0087-312X
Lori GarmanDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Nicholas CejdaDepartment of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Nathan PezantDepartment of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Astrid RasmussenDepartment of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0001-7744-2948
Benjamin A RybickiDepartment of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.ORCID 0000-0003-3190-3467
Albert M LevinDepartment of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.
Penelope BenchekDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Chetan SeshadriDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Harriet Mayanja-KizzaDepartment of Medicine, Makerere University and Mulago Hospital, Kampala, Uganda.
Michael C IannuzziDepartment of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.
Catherine M SteinDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Courtney G MontgomeryDepartment of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Oklahoma Medical Research Foundation · USHenry Ford Health System · USCase Western Reserve University · USMulago Hospital · UGUniversity of Oklahoma Health Sciences Center · USUniversity of Washington · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TIMOTHY M VANWAGONER · 2013 to 2026
$68.2M
Comprehensive Genome Interrogation of African American Sarcoidosis FamiliesR01HL113326 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MONTGOMERY, COURTNEY · 2012 to 2022
$8.7M
Quantitative Analysis Core P30GM110766 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2014 to 2018
$6.1M
Molecular Basis of Immunity - Kirschtein-NRSAT32AI007633 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CUNNINGHAM, MADELEINE W. · 2001 to 2022
$4.0M
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-InfectionR33AI138272 · NIAID · UNIVERSITY OF WASHINGTON · PI BOOM, W. HENRY, HAWN, THOMAS R · 2020 to 2022
$3.4M
NHLBI NIH HHS R01 HL113326NIAID NIH HHS R33 AI138272NIAID NIH HHS T32 AI007633NIGMS NIH HHS P30 GM110766NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Tuberculosis and sarcoidosis are inflammatory diseases characterized by granulomas that may occur in any organ but are often found in the lung. The panoply of classical human leukocyte antigen (HLA) alleles associated with occurrence and/or severity of both diseases varies considerably across studies. This heterogeneity of results, due to variation in factors like ancestry and disease subphenotype, as well as the use of simple modeling strategies to elucidate likely complex relationships, has made conclusions about underlying commonalities difficult. Here we perform HLA association analyses in individuals of African ancestry, using a greater resolution to include subphenotypes of disease and employing more comprehensive analytical techniques. Using a novel application of nearest-neighbor feature selection to score allelic importance, we investigated HLA allele association with Mycobacterium tuberculosis exposure outcomes in the first analysis of both latent Mycobacterium tuberculosis infection and active disease compared with those who, despite long-term exposure to active index cases, have neither positive diagnostic tests nor display clinical symptoms. We also compared persistent to resolved sarcoidosis. This led to the identification of novel HLA associations and evidence of main effects and interaction effects. We found strikingly similar main effects and interaction effects at HLA-DRB1, -DQB1, and -DPB1 in those resistant to tuberculosis (either latent or active) and persistent sarcoidosis.

Indexed as

Mycobacterium tuberculosisSarcoidosisTuberculosisAllelesGene FrequencyGenetic Predisposition to DiseaseHLA-DRB1 ChainsHumansHLA-DRB1 ChainsepistasisHLAMycobacterium tuberculosisnearest-neighbor feature selectionresistance to infectionsarcoidosis

Identifiers

PMID35702824
PMCPMC10237150
OpenAlexW4282961092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.